01.11.2012 Views

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

DRIVIN G ROWTH - Dr. Reddy's

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SHE PRACTICES HAVE EVOLVED FROM AN<br />

END-OF-PIPE APPROACH— TREATING<br />

GENERATED WASTE—TO ONE THAT ATTEMPTS<br />

TO MINIMISE POLLUTANTS AT THE SOURCE.<br />

BULK MANUFACTURING<br />

FACILITIES<br />

DR. REDDY’S BULK<br />

MANUFACTURING facilities aim at a<br />

robust waste management infrastructure<br />

that is not product specific. The target is to<br />

continuously upgrade the facilities.<br />

This effort is reflected in its investments.<br />

In 2001-2002, the SBU Bulk Actives of the<br />

Company spent more than 15 % of its<br />

capital expenditure on setting up<br />

Environment Management Systems. A<br />

similar proportion is targeted this year as<br />

well. The results are visible in reduced<br />

water consumption and lower effluent<br />

discharges. One of our units is progressing<br />

towards zero effluent discharge facility. All<br />

the bulk facilities have streamlined solid<br />

waste disposal to a secured landfill site and<br />

to authorised third parties. The organic<br />

fraction of the solid wastes are reprocessed<br />

as fuel at some of our facilities.<br />

The environmental impact of any new<br />

activity needs to be evaluated before its<br />

commencement. At the bulk facilities, a<br />

process named “Symphony” assesses the<br />

environmental impact of each product from<br />

the initial stages of product development.<br />

GENERICS PLANT<br />

DR. REDDY’S GENERICS FACILITY<br />

meet the highest international standards in<br />

drug manufacture. Its desire to match this<br />

on the environmental front led to its<br />

implementing the Environmental<br />

Management System (ISO 14001 Standard).<br />

The facility has obtained ISO 14001<br />

certification in the month of May 2002.<br />

EMERGING BUSINESSES<br />

CYTOTOXIC DIVISION<br />

The Cytotoxic division is being built to meet<br />

the USFDA standards. SHE practices are<br />

integrated into the design, covering every<br />

aspect of handling the product in both bulk<br />

and formulation stages. The facilities are<br />

being designed with total containment<br />

philosophy, to ensure minimal exposure of<br />

the product to the person.The facility is<br />

being continuously evaluated from the<br />

engineering process angles to avoid and<br />

minimize the discharge impact from the<br />

inception of the facility.<br />

DR. REDDY’S LABORATORIES LTD. | SAFETY, HEALTH AND ENVIRONMENT | ANNUAL REPORT 2001-2002<br />

23

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!